✦ LIBER ✦

Docetaxel for Malignant Mesothelioma: Phase II Study of the Eastern Cooperative Oncology Group

✍ Scribed by Chandra P. Belani; Sudeshna Adak; Seena Aisner; Philip J. Stella; Nathan Levitan; David H. Johnson

Book ID: 119935502
Publisher: CIG Media Group, LP.
Year: 2004
Tongue: English
Weight: 146 KB
Volume: 6
Category: Article
ISSN: 1525-7304
DOI: 10.3816/clc.2004.n.020

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Malignant mesothelioma. The eastern coop

Malignant mesothelioma. The eastern cooperative oncology group (ECOG) experience

✍ Harvey J. Lerner; David A. Schoenfeld; Ann Martin; G. Falkson; E. Borden 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB 👁 2 views

The Eastern Cooperative Oncology Group has conducted a retrospective review of their experience of 96 patients with a tissue diagnosis of malignant mesothelioma treated between 1972 and 1980 on four separate sarcoma chemotherapy protocols. Thirty-two of the 96 patients were diagnosed and treated in

Phase II trial of PCNU in advanced malig

Phase II trial of PCNU in advanced malignant melanoma: an Eastern Cooperative Oncology Group pilot study

✍ Robert H. Earhart; Franco M. Muggia; Frederick M. Golomb 📂 Article 📅 1985 🏛 Springer US 🌐 English ⚖ 327 KB

PCNU, a chloroethylnitrosourea with high alkylating activity, low carbamoylating activity, optimal octanol: water partition coefficient and broad activity in animal systems, was administered to 32 evaluable patients with measurable metastatic melanoma by brief intravenous infusions every six weeks.

Paclitaxel for malignant pleural mesothe

Paclitaxel for malignant pleural mesothelioma: a phase II study of the EORTC Lung Cancer Cooperative Group

✍ van Meerbeeck, J; Debruyne, C; van Zandwijk, N; Postmus, PE; Pennucci, MC; van B 📂 Article 📅 1996 🏛 Nature Publishing Group 🌐 English ⚖ 673 KB

Phase II Study of Interferon Gamma in Ma

Phase II Study of Interferon Gamma in Malignant Carcinoid Tumors (E9292): A Trial of the Eastern Cooperative Oncology Group

✍ Keith Stuart; Donna E. Levy; Tom Anderson; Constantine A. Axiotis; Janice P. Dut 📂 Article 📅 2004 🏛 Springer US 🌐 English ⚖ 82 KB

A phase II study of Didemnin B (NSC 3253

A phase II study of Didemnin B (NSC 325319) in advanced malignant melanoma: an Eastern Cooperative Oncology Group study (PB687)

✍ Howard Hochster; Ruth Oratz; David S. Ettinger; Ernest Borden 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 56 KB

A phase II evaluation of cisplatin in un

A phase II evaluation of cisplatin in unresectable diffuse malignant mesothelioma: A Southwest Oncology Group Study

✍ Bernard L. Zidar; Stephanie Green; H. I. Pierce; Ralph W. Roach; Stanley P. Balc 📂 Article 📅 1988 🏛 Springer US 🌐 English ⚖ 240 KB

Cisplatin was given intravenously to 35 evaluable patients with unresectable malignant mesothelioma on Southwest Oncology Group (SWOG) Study 8418. Five patients (14.3%) achieved partial response with median response duration of six months (range 2-12 months); eleven patients (31.4%) had stable disea